Infanrix
Details for Infanrix vaccine and its components.
Sponsor:
GlaxoSmithKline Australia
Administration route:
Intramuscular injection
Vaccine group:
Combination vaccines
Registered for primary immunisation in infants aged 2–12 months and as a booster in children aged 15 months to 6 years.
DTPa — diphtheria-tetanus-acellular pertussis combination vaccine
Each 0.5 mL monodose vial or pre-filled syringe contains:
- ≥30 IU diphtheria toxoid
- ≥40 IU tetanus toxoid
- 25 µg pertussis toxoid
- 25 µg filamentous haemagglutinin
- 8 µg pertactin
Adsorbed onto 0.5 mg aluminium as aluminium hydroxide.
For full details, refer to the product information and consumer medicine information sheets for Infanrix vaccine available on the TGA website.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Definitions
- DTPa
- diphtheria-tetanus-acellular pertussis vaccine
- IU
- international units
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/infanrix.